Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Meiragtx Holdings Plc (MGTX)
NASDAQ:MGTX
Meiragtx Holdings (MGTX) Stock Price & Analysis
396 Followers
MGTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.49 - $8.35
Previous Close$5.71
Volume68.72K
Average Volume (3M)145.24K
Market Cap
$367.19M
Enterprise Value$326.89M
Total Cash (Recent Filing)$129.57M
Total Debt (Recent Filing)$89.26M
Price to Earnings (P/E)-4.5
Beta1.45
Next Earnings
Aug 08, 2024EPS Estimate
-$0.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.28
Shares Outstanding64,306,613
10 Day Avg. Volume141,451
30 Day Avg. Volume145,237
Standard Deviation0.18
R-Squared0.16
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)2.66
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-6.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.97
Forecast
1Y Price Target
$17.33Price Target Upside203.50% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Meiragtx Holdings News
Bulls Say, Bears Say
Bulls Say
Clinical DevelopmentThe company has aligned with FDA on requirements for ongoing phase 2 AQUAx2 clinical trial, which supports potential BLA filing and adds another asset to watch.
Financial ForecastMultiple partnerships have bolstered the company's cash position, providing a solid financial foundation for near-term operations.
Strategic InvestmentThe company has secured a strategic investment from Sanofi and an asset purchase agreement with Janssen, enhancing the financial stability and future growth prospects.
Bears Say
Clinical Trial ResultsIn comparing with the prior data, there is observed variability with some patients showing a decline in improvement scores.
Market UncertaintyThere are concerns about uncertainties around launch and ramp trajectories for gene therapy modalities.
Stock PerformanceStock has traded down this year, underperforming the broader biotech index.
---
Ownership Overview
35.08% Insiders
4.18% Mutual Funds
52.95% Other Institutional Investors
7.78% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MGTX FAQ
What was Meiragtx Holdings Plc’s price range in the past 12 months?
Meiragtx Holdings Plc lowest stock price was $3.49 and its highest was $8.35 in the past 12 months.
What is Meiragtx Holdings Plc’s market cap?
Currently, no data Available
When is Meiragtx Holdings Plc’s upcoming earnings report date?
Meiragtx Holdings Plc’s upcoming earnings report date is Aug 08, 2024 which is in 82 days.
How were Meiragtx Holdings Plc’s earnings last quarter?
Meiragtx Holdings Plc released its earnings results on May 09, 2024. The company reported -$0.32 earnings per share for the quarter, beating the consensus estimate of -$0.505 by $0.185.
Is Meiragtx Holdings Plc overvalued?
According to Wall Street analysts Meiragtx Holdings Plc’s price is currently Undervalued.
Does Meiragtx Holdings Plc pay dividends?
Meiragtx Holdings Plc does not currently pay dividends.
What is Meiragtx Holdings Plc’s EPS estimate?
Meiragtx Holdings Plc’s EPS estimate is -$0.4.
How many shares outstanding does Meiragtx Holdings Plc have?
Meiragtx Holdings Plc has 64,306,610 shares outstanding.
What happened to Meiragtx Holdings Plc’s price movement after its last earnings report?
Meiragtx Holdings Plc reported an EPS of -$0.32 in its last earnings report, beating expectations of -$0.505. Following the earnings report the stock price went down -0.778%.
Which hedge fund is a major shareholder of Meiragtx Holdings Plc?
Among the largest hedge funds holding Meiragtx Holdings Plc’s share is Perceptive Advisors LLC. It holds Meiragtx Holdings Plc’s shares valued at 80M.
---
Meiragtx Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$17.33 (203.50% Upside)
$17.33 (203.50% Upside)
Hedge Fund Trend
Decreased
By 5.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.6%
Last 30 Days ▼ 6.2%
Last 30 Days ▼ 6.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.84%
12-Months-Change
Fundamentals
Return on Equity
-69.92%
Trailing 12-Months
Asset Growth
7.32%
Trailing 12-Months
Company Description
Meiragtx Holdings Plc
MeiraGTx Holdings Plc is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. It operates through the United States and United Kingdom geographical segments. Its pipeline includes AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1, and AAV-UPF1. The company was founded on March 20, 2015 and is headquartered in New York, NY.
---
MGTX Stock 12 Month Forecast
Average Price Target
$17.33
▲(203.50% Upside)
Technical Analysis
Best Analysts Covering MGTX
1 Year
1 Year Success Rate
4/15 ratings generated profit
1 Year Average Return
-15.34%
reiterated a buy rating 10 days ago
Copying Luca Issi's trades and holding each position for 1 Year would result in 26.67% of your transactions generating a profit, with an average return of -15.34% per trade.
---